151 related articles for article (PubMed ID: 35265528)
1. Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer.
Li S; Zhang G; Lu Y; Zhao T; Gao C; Liu W; Piao Y; Chen Y; Huang C; Chang A; Hao J
Front Oncol; 2022; 12():841819. PubMed ID: 35265528
[TBL] [Abstract][Full Text] [Related]
2. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
Kim NH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
[TBL] [Abstract][Full Text] [Related]
3. Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer.
Kawai M; Hirono S; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Tanioka K; Yamaue H
Surgery; 2019 Jun; 165(6):1151-1160. PubMed ID: 30765142
[TBL] [Abstract][Full Text] [Related]
4. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.
Guo SW; Shen J; Gao JH; Shi XH; Gao SZ; Wang H; Li B; Yuan WL; Lin L; Jin G
Surgery; 2020 Dec; 168(6):1003-1014. PubMed ID: 32321665
[TBL] [Abstract][Full Text] [Related]
5. The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma.
Li S; Xu H; Wang W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Wu C; Liu L
Cancer Manag Res; 2019; 11():3327-3337. PubMed ID: 31114368
[No Abstract] [Full Text] [Related]
6. A Simple Model Established by Blood Markers Predicting Overall Survival After Radical Resection of Pancreatic Ductal Adenocarcinoma.
Zhang LX; Chen L; Xu AM
Front Oncol; 2020; 10():583. PubMed ID: 32426277
[No Abstract] [Full Text] [Related]
7. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
8. Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable Pancreatic Ductal Adenocarcinoma.
Li X; Li S; Liu L; Hong J; Zhao T; Gao C
J Cancer; 2020; 11(1):9-15. PubMed ID: 31892968
[TBL] [Abstract][Full Text] [Related]
9. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.
Xu HX; Liu L; Xiang JF; Wang WQ; Qi ZH; Wu CT; Liu C; Long J; Xu J; Ni QX; Yu XJ
Surgery; 2017 Feb; 161(2):373-384. PubMed ID: 27838102
[TBL] [Abstract][Full Text] [Related]
10. Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.
Sugawara T; Ban D; Nishino J; Watanabe S; Maekawa A; Ishikawa Y; Akahoshi K; Ogawa K; Ono H; Kudo A; Tanaka S; Tanabe M
PLoS One; 2021; 16(4):e0249885. PubMed ID: 33844700
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic cancer.
Kwon CH; Seo HI; Kim DU; Han SY; Kim S; Lee NK; Hong SB; Ahn JH; Park YM; Noh BG
Korean J Clin Oncol; 2023 Jun; 19(1):11-17. PubMed ID: 37449394
[TBL] [Abstract][Full Text] [Related]
12. A scoring model for predicting early recurrence of gastric cancer with normal preoperative tumor markers: A multicenter study.
Zheng CY; Wu J; Chen CS; Huang ZN; Tang YH; Qiu WW; He QC; Lin GS; Chen QY; Lu J; Wang JB; Lin JX; Cao LL; Lin M; Tu RH; Xie JW; Li P; Huang CM; Zheng YH; Zheng CH
Eur J Surg Oncol; 2023 Nov; 49(11):107094. PubMed ID: 37797381
[TBL] [Abstract][Full Text] [Related]
13. Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram-based prediction.
Pu N; Yin H; Zhao G; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Cancer; 2019; 10(24):5935-5943. PubMed ID: 31762803
[No Abstract] [Full Text] [Related]
14. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection.
Zhang LP; Ren H; Du YX; Wang CF
World J Gastroenterol; 2020 Dec; 26(46):7382-7404. PubMed ID: 33362391
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
16. Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk Score.
Kim DW; Lee SS; Kim SO; Kim JH; Kim HJ; Byun JH; Yoo C; Kim KP; Song KB; Kim SC
Radiology; 2020 Sep; 296(3):541-551. PubMed ID: 32662759
[TBL] [Abstract][Full Text] [Related]
17. Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma.
Salmiheimo A; Mustonen H; Stenman UH; Puolakkainen P; Kemppainen E; Seppänen H; Haglund C
PLoS One; 2016; 11(9):e0163064. PubMed ID: 27632196
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the physiobiological parameter-based grading system for predicting the long-term prognosis after curative surgery for resectable pancreatic cancer.
Abe T; Amano H; Kobayashi T; Hattori M; Hanada K; Nakahara M; Ohdan H; Noriyuki T
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):613-619. PubMed ID: 32978015
[TBL] [Abstract][Full Text] [Related]
19. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study.
Matsumoto I; Murakami Y; Shinzeki M; Asari S; Goto T; Tani M; Motoi F; Uemura K; Sho M; Satoi S; Honda G; Yamaue H; Unno M; Akahori T; Kwon AH; Kurata M; Ajiki T; Fukumoto T; Ku Y
Pancreatology; 2015; 15(6):674-80. PubMed ID: 26467797
[TBL] [Abstract][Full Text] [Related]
20. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]